What are the top competitors of DCTH in Healthcare sector?

The top competitors of DCTH in the Healthcare sector are: Accuray Incorporated (ARAY), Envoy Medical, Inc. (COCHW).

Which has better valuations & earnings, DCTH or its competitors?

DCTH has a market cap of 481.5M and a Dividend Yield of N/A compared to its competitors.

Which stock is more profitable: DCTH or its competitors?

DCTH has an EPS of $-0.45, while ARAY has an EPS of $-0.04. So, DCTH is more profitable compared to ARAY.

What is DCTH stock volatility and risk in terms of investment?

DCTH has daily volatility of 3.42% as compared to its competitor ARAY which is 3.23%. DCTH is more volatile as compared to competitors and has high risk.

Is DCTH stock profitable?

DCTH has a Return on Equity (ROE) of -0.35%. So, DCTH is more profitable.

What is DCTH stock’s 52 weeks high and low?

DCTH stock has a 52-week high of ($18.23) and a low of ($7.17).

What was the average volume of DCTH stock?

The average volume of DCTH is (489.3K) in terms of investment.

Delcath Systems, Inc. (DCTH) Competitors

Delcath Systems, Inc. DCTH Peers

See (DCTH) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Specialties Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
DCTH	$13.83	-2.36%	481.5M	-30.72	-$0.45	N/A
ARAY	$1.22	-0.81%	125.7M	-30.50	-$0.04	N/A
COCHW	$0.04	+16.44%	36.1M	N/A	N/A	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

DCTH vs ARAY Comparison

DCTH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DCTH stands at 481.5M. In comparison, ARAY has a market cap of 125.7M. Regarding current trading prices, DCTH is priced at $13.83, while ARAY trades at $1.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DCTH currently has a P/E ratio of -30.72, whereas ARAY's P/E ratio is -30.50. In terms of profitability, DCTH's ROE is -0.35%, compared to ARAY's ROE of +0.01%. Regarding short-term risk, DCTH is more volatile compared to ARAY. This indicates potentially higher risk in terms of short-term price fluctuations for DCTH.

Delcath Systems, Inc.